GÜNDÜZ, F. F. Et Al. 2022. Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy. ınternational Liver congress ILC 2022 (EASL) .

GÜNDÜZ, F. F., DURAK, S., ÜNSAL, Y., DEMİR, M., MELEKOĞLU ELLİK, Z., YILDIRIM, A. E., ... ADANIR, H.(2022). Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy . ınternational Liver congress ILC 2022 (EASL)

GÜNDÜZ, FATMA Et Al. "Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy," ınternational Liver congress ILC 2022 (EASL), 2022

GÜNDÜZ, FATMA F. Et Al. "Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy." ınternational Liver congress ILC 2022 (EASL) , 2022

GÜNDÜZ, F. F. Et Al. (2022) . "Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy." ınternational Liver congress ILC 2022 (EASL) .

@conferencepaper{conferencepaper, author={FATMA FEYZA GÜNDÜZ Et Al. }, title={Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy}, congress name={ınternational Liver congress ILC 2022 (EASL)}, city={}, country={}, year={2022}}